Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  GlaxoSmithKline plc    GS7   GB0009252882

Real-time Quote. Real-time Tradegate - 02/10 05:46:58 am
17.578 EUR   +1.26%
02/09 VALNEVA : Signs New R&D Collaboration with GlaxoSmithKline for the E..
02/09 GLAXOSMITHKLINE : slips 1.3% on Q3 results
02/09DJSanofi Profit Hit By Falling Diabetes Revenue -- Update
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo GlaxoSmithKline plc
Develops, manufactures and distributes vaccines and other pharmaceutical products

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.

It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.

The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.

The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.

The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Managers
NameAgeSinceTitle
Andrew Witty502008Chief Executive Officer & Executive Director
Philip Hampton522015Non-Executive Chairman
Simon Dingemans512011Chief Financial Officer & Executive Director
Deryck Charles Maughan672004Senior Independent Non-Executive Director
Stephanie A. Burns, PhD612007Independent Non-Executive Director
Moncef Slaoui, PhD552006Executive Director & Chairman-Global Vaccines
Daniel K. Podolsky, PhD612006Independent Non-Executive Director
Roy Malcolm Anderson672007Independent Non-Executive Director
Stacey Cartwright512011Independent Non-Executive Director
Judy Carol Lewent662011Independent Non-Executive Director
Shareholders
NameEquities%
BlackRock Investment Management (UK) Ltd. 199,772,316 4.10%
Legal & General Investment Management Ltd. 149,809,659 3.08%
The Vanguard Group, Inc. 111,620,000 2.29%
Norges Bank Investment Management 102,534,000 2.11%
Capital Research & Management Co. (Global Investors) 91,512,000 1.88%
Schroder Investment Management Ltd. 66,547,339 1.37%
State Street Global Advisors Ltd. 64,771,772 1.33%
Aberdeen Asset Investments Ltd. 64,630,000 1.33%
Threadneedle Asset Management Ltd. 58,626,000 1.20%
Woodford Investment Management LLP 55,837,564 1.15%
Holdings
NameEquities%Valuation
Aspen Pharmacare Holdings Limited (APNJ) 28,234,3796.19%563,904,076 USD
Theravance Biopharma Inc (TBPH) 8,343,79222.1%136,754,751 USD
GlaxoSmithKline S.A.E. 76,161,37891.2%103,298,439 USD
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSM) 555,081,92646.4%95,374,177 USD
Dong-A Socio Holdings Co Ltd (000640) 409,6938.78%59,223,884 USD
GALAPAGOS (GLPG) 508,6441.30%31,362,170 USD
Allergy Therapeutics plc (AGY) 10,118,0001.72%4,399,306 USD
NeuroSearch A/S (NEUR) 1,950,5007.94%716,048 USD
Serendex Pharmaceuticals A/S (SENDEX) 164,3550.10%15,831 USD
Response Genetics, Inc. (RGDXQ) 5,000,00012.9%5,000 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
ALLERGAN PLC
BRISTOL-MYERS SQU..
SANOFI
GLAXOSMITHKLINE P..
NOVO NORDISK A/S
BAYER AG
ELI LILLY AND CO
ASTRAZENECA PLC
TEVA PHARMACEUTIC..
ABBOTT LABORATORI..
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
VALEANT PHARMACEU..
SHIRE PLC
MYLAN NV
Sector Pharmaceuticals
GlaxoSmithKline plc : Connections
The 100 Group
The Council for Industry & Higher Education
European Federation of Pharmaceutical Industries & Assns
Business Council for Britain
Singapore Economic Development Board
National Theatre of Scotland
The Natural History Museum
Carnegie Hall Society, Inc.
Imperial College London
NYU Langone Medical Center
Burberry Spain SA
The Trilateral Commission
American Academy of Arts & Sciences
The University of Texas Southwestern Medical Center
The British Museum
Southwestern Medical Foundation
Federal Reserve Bank of New York
National Academy of Sciences
The University of Nottingham
Council of Teaching Hospitals
Pharmaceutical Research & Manufacturers of America
French Academy of Sciences
United Kingdom Department for Business, Innovation & Skills
Pearson Education Ltd.
American Chemical Society
Harvey Nichols Group Ltd.
Biotechnology Industry Organization
GlaxoSmithKline, Inc.
International AIDS Vaccine Initiative, Inc.
Rockefeller Family Trust, Inc.
Longwood Fund Management LLC
Massachusetts Institute of Technology
Company contact information
980 Great West road
TW8 9GS Brentford, Greater London
United Kingdom

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE Eurotop 100, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem